The Relationship between the Myelodysplastic Syndromes and the Myeloproliferative Disorders

References

• Verhoef G., Meeus P., Stul M., Mecucci C., Cassiman J. T., van den Berghe H., Boogaerts M. A. Cyto‐genetic and molecular studies of the Philadelphia transloca‐tion in myelodysplastic syndromes. Cancer Genetics and Cytogenetics 1992; 59: 161–166
   PubMed Web of Science ®Google Scholar
• Dash S., Rao N. R., Deodhar S. D., Varma N. Malignant mastocytosis and myelodysplastic syndrome. British Journal of Haematology 1991; 79: 530–531
   PubMed Web of Science ®Google Scholar
• Travis W. D., Li C. ‐Y., Yam L. T., Bergstralh E. J., Swee R. G. Significance of systemic mast cell disease with associated hematologic diagnosis. Cancer 1988; 62: 965–912
   PubMed Web of Science ®Google Scholar
• Beris P. Primacy clonal myelodysplastic syndrome. Seminars in Hematology 1989; 26: 216–233
   PubMed Web of Science ®Google Scholar
• Neuwirtováa R., Mocikováa K., Musilová J., Jelinek J., Havlíek R., Michalová K., Adamkov M. Mixed myelodysplastic and rnyeloproliferative syndromes. Leukemia Research 1996; 20: 711–126
   Web of Science ®Google Scholar
• Maschek H., Georgii A., Kaloutsi V., Werner M., Bande‐car K., Kressel M. ‐G., Choritz H., Freund M., Hufnagl D. Myelofibrosis in myelodysplastic syndromes: a retrospective study of 352 patients. European Journal of Haematology 1992; 48: 208–214
   PubMed Web of Science ®Google Scholar
• Lukowicz D. E., Myers T. J., Grasso J. A., Albala M. M. Sideroblastic anemia terminating in myelofibrosis. American Journal of Hematology 1982; 13: 253–251
   PubMed Web of Science ®Google Scholar
• Williams M. D., Shinton N. K., Finney R. D. Primary acquired sideroblastic anaemia and myeloprolifera‐tive disease: a report of three cases. Clinical and Laboratory Haematology 1985; 7: 113–118
   PubMedGoogle Scholar
• Gupta R., Abdalla S. H., Bain B. J. Thrombocy‐tosis with sideroblastic erythropoiesis: a mixed myeloprolif‐erative/myelodysplastic syndrome. Leukemia & Lymphoma. 1998
   Web of Science ®Google Scholar
• Oscier D. G. Atypical chronic myeloid leukaemia. Is it a separate entity?. Leukemia Research 1994; 18(Suppl, 37)
   Google Scholar
• Mufti G. J., Hamblin T. J., Seabright M. Acute transformation of a myeloproliferative state in sideroblastic anaemia with abnormal karyotype. Journal of Medical Genetics 1982; 19: 478
   PubMed Web of Science ®Google Scholar
• Craig A., Geary C. G., Love E. M., Liu‐Yin J. Red cell hypoplasia, thrombocytosis, and leucocytosis: myel‐odysplastic and proliferative syndrome. Journal of Clinical Pathology 1988; 41: 1168–1170
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C. Proposals for the classification of the myelodysplastic syndromes. British Journal of Haematology 1982; 51: 189–199
   PubMed Web of Science ®Google Scholar
• Bennett J. M., Catovsky D., Daniel M. T., Flandrin G., Galton D. A. G., Gralnick H. R., Sultan C., Cox C. The chronic myeloid Ieukaemias: guidelines for distinguishing granulocytic, atypical chronic myeloid, and chronic myelomonocytic leukaemia. Proposals from the French‐American‐British Cooperative Leukaemia Group. British Journal of Haematology 1994; 87: 746–754
   PubMed Web of Science ®Google Scholar
• Germing U., Gatterman N., Minning H., Heyll A., Aul C. Problems in the classification of CMML‐dysplastic versus proliferative type. Leukemia Research 1997; 22: 871–878
   Web of Science ®Google Scholar
• Cervera J., Sanz G. F., Vallespi T., del Caflizo M. C., Irri‐guible R., Löpez F., Sahchez‐Morata C., Larrea L., Blanco A., Bentloch L., Juliá A., San Miguel J. F., Sanz M. A. Does WBC really define two different subtypes of chronic myelomonocytic leukemia (CMML)?. Leukemia Research 1997; 21(Suppl 1)S7
   Google Scholar
• Oscier D., Chapman R. Commentary: the classification of chronic myelomonocytic leukaemia. Leukemia Research 1998; 22: 879–880
   PubMed Web of Science ®Google Scholar
• Matsushima T., Murukami H., Tsuchiya J. Myelodysplastic syndrome with bone marrow eosinophilia: clinical and cytogenetic features. Leukemia & Lymphoma 1994; 15: 491–497
   PubMed Web of Science ®Google Scholar
• Neri G., Daniel A., Hammond N. Chromosome 16q, eosinophilia, and leukemia. Cancer Genetics and Cytogenetics 1985; 14: 371–372
   PubMed Web of Science ®Google Scholar
• Kobayashi H., Kitano K., Shimodaira S., Ishida F., Saito H., Sonoyama M., Enokihara H., Furuta S. Eosinophilia in myelodysplastic syndrome with a (1221) (q23;q22) translocation. Cancer Genetics and Cytogenetics 1993; 68: 95–98
   PubMed Web of Science ®Google Scholar
• Inaba T., Shimazaki C., Inaba E., Hirata T., Ashihara E., Okhawa K., Oku N., Goto H., Murakami S., Fujita N., Misawa S., Nakagawa M. Inversion of chromosome 16 and eosinophilia in refractory anemia with ring sid‐eroblasts: report of a case. American Journal of Hematology 1993; 44: 134–138
   PubMed Web of Science ®Google Scholar
• Imai Y., Yasuhara S., Hanafusa N., Ohsaka A., Enokihara H., Tomizuka H., Sonoyama M., Miura Y., Tohda S., Nara N., Takahoshi A. Clonal involvement of eosino‐phils in therapy‐related myelodysplastic syndrome with eosinophilia, translocation t(1;7) and lung cancer. British Journal of Haematology 1996; 95: 710–714
   PubMed Web of Science ®Google Scholar
• Tinegate H. N., Chetty M. N. Basophilia as features of the myelodysplastic syndrome. Clinical and Laboratory Haematology 1986; 8: 269–271
   PubMedGoogle Scholar
• El‐Rifai W., Pettersson T., Larramendy M. L., Knuutila S. Lineage involvement and karyotype in a patient with myelodysplasia and blood basophilia. European Journal of Haematology 1994; 53: 288–292
   PubMed Web of Science ®Google Scholar
• Solé R., Torrabedella M., Granada I., Florensa L., Vallespi T., Ribera J. M., Imguible D., Mella F., Woessner S. Isochromosome 17q as a sole anomaly: a distinct myelodysplastic syndrome entity. Leukemia Research 1993; 17: 717–720
   PubMed Web of Science ®Google Scholar
• Bain B. J. Eosinophilic leukaemias and the idiopathic hypereosinophilic syndrome. British Journal of Haematology 1996; 95: 2–9
   PubMed Web of Science ®Google Scholar
• Ross F. M., Hamilton M., Cook M. K., Irving J. B. A myelodysplastic syndrome with eosinophilia associated with a break in the short arm of chromosome 16. Leukemia 1987; 1: 680–681
   PubMed Web of Science ®Google Scholar
• Pearson M. G., Vardiman J. W., Le Beau M. M., Rowley J. D., Schwartz S., Kerman S. L., Cohen M. M., Fleischman E. W., Prigogina E. L. Increased numbers of marrow basophils may be associated with a t(6;9) in ANLL. American Journal of Hematology 1985; 18: 393–403
   PubMed Web of Science ®Google Scholar
• Keene P., Mendelow B., Pinto M. R., Bezwode W., Mac‐Dougall L., Falkson G., Ruff P., Bernstein R. Abnormalities of 12p13 and malignant proliferation of eosi‐nophils: a nonrandom association. British Journal of Haematology 1987; 67: 25–31
   PubMed Web of Science ®Google Scholar
• Ma S. K., Wong K. R., Chan J. K. C., Kwong Y. L. Refractory cytopenia with t(1;7), +8 abnormality and dysplastic eosinophils showing intranuclear Charcot‐Leyden crystals: a fluorescence in situ hybridization study. British Journal of Haematology 1995; 90: 216
   PubMed Web of Science ®Google Scholar
• Pérez‐Losada A., Woessner S., S61e F., Florensa L., Granena A. Refractory anaemia with hypereosino‐philia and clonal abnormal metaphases detected in the neu‐trophil granulopoietic series. Acta Haematologica 1994; 91: 80–83
   PubMed Web of Science ®Google Scholar
• Jani K., Kempski H. M., Reeves B. R. A case of myelodysplasia with eosinophilia having a translocation t(5;12)(q31;q13) restricted to myeloid cells but not involving eosinophils. British Journal of Haematology 1994; 87: 57–60
   PubMed Web of Science ®Google Scholar
• van den Berghe H., Vermaelen K., Mecucci C., Barbieri D., Tricot G. The 5q‐ anomaly. Cancer Genetics and Cytogenetics 1985; 17: 189–255
   PubMed Web of Science ®Google Scholar
• Jondeau K., Bouscary D., Viguié F., Picard R., Melle J., Lopez I., Fontenay‐Roupie M., Dreyfus R. Thrombocytemia (sic) and abnormal megakaryopoiesis associated with abnormality of chromosome lp34 in myelodysplastic syndromes. Leukemia 1996; 10: 1692–1695
   PubMed Web of Science ®Google Scholar
• Cuneo A., Tomasi P., Ferrari L., Balboni M., Piva N., Fagioli R., Castoldi G. Cytogenetic analysis of different cellular populations in chronic myelomonocytic leukemia. Cancer Genetics and Cytogenetics 1989; 37: 29–37
   PubMed Web of Science ®Google Scholar
• Dewald G. W., Davis M. P., Pierre R. V., O'Fallon J. R., Hoagland H. C. Clinical characteristics and prognosis of 50 patients with a myeloproliferative syndrome and deletion of part of the long arm of chromosome 5. Blood 1985; 66: 189–197
   PubMed Web of Science ®Google Scholar
• Koike T., Uesugi Y., Toba K., Narita M., Fuse I., Taka‐hashi M., Shibata A. 5q‐ syndrome presenting as essential thrombocythemia: myelodysplastic syndrome or chronic myeloproliferative disorders?. Leukemia 1995; 9: 517–518
   PubMed Web of Science ®Google Scholar
• Norrby A., Ridell B., Swolin B., Westin J. Rearrangement of chromosome No. 3 in a case of preleukemia with thrombocytosis. Cancer Genetics and Cytogenetics 1982; 5: 257–263
   PubMed Web of Science ®Google Scholar
• Carroll A. J., Poon M. ‐C., Robinson C., Crist W. M. Sideroblastic anaemia associated with thrombocytosis and a chromosome 3 abnormality. Cancer Genetics and Cytogenetics 1986; 22: 183–187
   PubMed Web of Science ®Google Scholar
• Secker‐Walker L., Mehta A., Bain B. on behalf of the UKCCG Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group Study. British Journal of Haematology 1995; 91: 490–502
   PubMed Web of Science ®Google Scholar
• Parlier V., Tiainen M., Beris Ph., Miescher P. A., Knuutila S., Bellomo Jotterand M. Trisomy 8 detection in granulomonocytic, erythrocytic and megakaryocytic lineages by chromosome in situ suppression hybridization in a case of refractory anaemia with ringed sideroblasts complicating the course of paroxysmal nocturnal haemoglobinuria. British Journal of Haematology 1992; 81: 286–264
   Web of Science ®Google Scholar
• Longo L., Bessler M., Beris P., Swirsky D., Luzzatto L. Myelodysplasia in a patient with pre‐existing paroxysmal nocturnal haemoglobinuria: a clonal disease originating within another clonal disease. British Journal of Haematology 1994; 87: 401–403
   PubMed Web of Science ®Google Scholar
• van Kamp H., Smit J. W., van den Berg E., Halie M. R., Vellenga E. Myelodysplasia following paroxysmal nocturnal haemoglobinuria: evidence for the emergence of a separate clone. British Journal of Haematology 1994; 87: 399–400
   PubMed Web of Science ®Google Scholar